Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cyclic citrullinated peptide antibody

Known as: Anti-Perinuclear Factor Antibody, Cyclic citrullinated peptide Ab, ACPA 
An autoantibody directed against peptides or proteins whose arginine residues have been enzymatically converted to citrulline. It is often associated… Expand
National Institutes of Health

Related topics

Related topics

8 relations
AntibodiesCyclic citrullinated peptide Ab.IgG:PrThr:Pt:Ser:OrdCyclic citrullinated peptide Ab:ACnc:Pt:Ser:QnCyclic citrullinated peptide Ab:ACnc:Pt:Ser:Qn:IA
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis
Neutrophil NETs may contribute to pathogenesis of rheumatoid arthritis. Autoantigens Slip Through the NET Autoimmune diseases are… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
The aim of this study was to evaluate new and previously hypothesised non-genetic risk factors for serologic subtypes of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
Antibodies to citrullinated proteins (anti-cyclic-citrullinated peptide [anti-CCP] antibodies) are highly specific for rheumatoid… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
OBJECTIVE The main genetic risk factor for rheumatoid arthritis (RA), the HLA region, has been known for 25 years. Previous… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.
OBJECTIVE Rheumatoid arthritis (RA) is a common, severe, chronic inflammatory joint disease. Since the disease may initially be… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
OBJECTIVE To investigate the role of anti-cyclic citrullinated peptide antibody (anti-CCP) for the prediction of radiological… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
OBJECTIVE To evaluate the prevalence and predictive value of anti-cyclic citrullinated peptide (anti-CCP) antibodies in… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
Objective: To study the value of antibodies to citrullinated proteins/peptides for predicting joint outcomes in patients with… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
OBJECTIVE Since modern treatment of rheumatoid arthritis (RA) is shifting toward aggressive antirheumatic therapy in an early… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
OBJECTIVE To study the predictive value of anticyclic citrullinated peptide antibody (anti-CCP) in patients with recent-onset… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE